… a phase I clinical study using autologous tumor lysate-pulsed… RNF43 is up-regulated in >
80% colorectal cancer tissues as … RNF43 peptide pulse dendritic cells and RNF43 peptide …

… of dendritic cell vaccination in one patient with advanced, … lysate-pulsed DCs. The median
PFS was improved at 18.3 … DC vaccine in 20 metastatic colorectal cancer patients, whose …

… strategies such as dendritic cell (DC), peptide, tumor cell, and viral vector … DCs pulsed with
melanoma cell lysate from DDM-1.13, a clone of the FM3 melanoma cell line selected for its …

… Immunization of mice with CSC lysate-pulsed DCs was able … malignant tumors including
melanoma, in which dendritic cell-… few studies have been shown that DC-based CSC vaccines …

… alone or in combination with dendritic cells (DCs). Other … A clinical trial which combined a
mutant RAS peptide vaccine with … therapy consisting of tumor lysate-pulsed DCs and CIKs after …

… (ii) improved DC vaccines loaded with the most immunogenic tumor-associated antigens.
Dendritic cells (DCs) are essential in immunity owing to their role in activating T cells, thereby …

… Dendritic cell (DC) vaccines utilize DCs loaded with tumor antigens ex vivo or transfected to
… clinical trials of melanoma and prostate cancer (52), are commonly studied in CRC as well. …

… , such as cytokine-induced killer (CIK), dendritic cell vaccine (DCV), or dendritic cell-cytokine…
immunotherapy for refractory lymphoblastic leukemia (4) and metastatic melanoma (5). …

… of tumors, such as melanoma and lung cancer, have also made this a viable therapy for
evaluation in colorectal cancer … ) RNA dendritic cells as a promising vaccine strategy. Basically, …

… melanoma, renal carcinoma, and even non-small cell … Dendritic Cell Vaccines As an essential
intermediary between antigen presentation and the T-cell effector response, dendritic cells …